SEC 13F Intelligence

Meag Munich Ergo, Kapitalanlagegesellschaft Mbh / TMO

Meag Munich Ergo, Kapitalanlagegesellschaft Mbh’s Thermo Fisher Scientific Inc Position

Does Meag Munich Ergo, Kapitalanlagegesellschaft Mbh own Thermo Fisher Scientific Inc (TMO)? Yes — 38.0K shares worth $15M (+0.43% of its 13F portfolio) as of Q2 2025, down from 80.1K shares the prior filed quarter.

Position Value
$15M
Q2 2025
Shares
38.0K
% of Portfolio
+0.43%
Quarters Held
26
currently held

Position History TMO

Reported value by quarter
Q4 ’18: $282,000Q4 ’18Q1 ’19: $5MQ2 ’19: $5MQ3 ’19: $8MQ4 ’19: $2MQ4 ’19Q1 ’20: $360,000Q2 ’20: $906,000Q3 ’20: $1MQ4 ’20: $1MQ4 ’20Q2 ’21: $5MQ3 ’21: $229,000Q4 ’21: $267,000Q1 ’22: $2MQ1 ’22Q2 ’22: $10MQ3 ’22: $9MQ4 ’22: $9MQ1 ’23: $14MQ1 ’23Q2 ’23: $13MQ3 ’23: $12MQ4 ’23: $13MQ1 ’24: $14MQ1 ’24Q2 ’24: $28MQ3 ’24: $32MQ4 ’24: $27MQ1 ’25: $40MQ1 ’25Q2 ’25: $15Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 202538.0K$15M+0.43%
Q1 202580.1K$40M+1.17%
Q4 202451.6K$27M+0.85%
Q3 202451.6K$32M+1.00%
Q2 202450.6K$28M+0.93%
Q1 202424.1K$14M+0.51%
Q4 202324.6K$13M+0.50%
Q3 202324.5K$12M+0.54%
Q2 202324.5K$13M+0.56%
Q1 202324.8K$14M+0.68%
Q4 202216.9K$9M+0.50%
Q3 202216.9K$9M+0.52%
Q2 202218.6K$10M+0.60%
Q1 20223.5K$2M+0.15%
Q4 2021400$267,000+0.02%
Q3 2021400$229,000+0.04%
Q2 202110.9K$5M+0.53%
Q4 20202.5K$1M+0.27%
Q3 20202.5K$1M+0.20%
Q2 20202.5K$906,000+0.17%
Q1 20201.3K$360,000+0.09%
Q4 20197.4K$2M+0.26%
Q3 201928.0K$8M+0.41%
Q2 201916.7K$5M+0.38%
Q1 201916.7K$5M+0.37%
Q4 20181.3K$282,000+0.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Meag Munich Ergo, Kapitalanlagegesellschaft Mbh’s full portfolio or all institutional holders of TMO.